Evidence map›Paper›PMID 35520919›Full record

ArticleRSC advances2019

Poly(norepinephrine)-coated FeOOH nanoparticles as carriers of artemisinin for cancer photothermal-chemical combination therapy.

Zi He, Huiling Su, Yuqing Shen, Wei Shi, Xin Liu, Yang Liu, Fuhui Zhang, Yansheng Zhang, Yanan Sun, Dongtao Ge

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Pharmaceutics · 2023
    Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zi HeKey Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University Xiamen 361005 China shiwei@xmu.edu.cn gedt@xmu.edu.cn +86 592 2188502 +86 592 2188502.
Huiling SuKey Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University Xiamen 361005 China shiwei@xmu.edu.cn gedt@xmu.edu.cn +86 592 2188502 +86 592 2188502.
Yuqing ShenXiamen Maternal and Child Health Hospital Xiamen 361003 China.
Wei ShiKey Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University Xiamen 361005 China shiwei@xmu.edu.cn gedt@xmu.edu.cn +86 592 2188502 +86 592 2188502.ORCID https://orcid.org/0000-0002-6718-7952
Xin LiuKey Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University Xiamen 361005 China shiwei@xmu.edu.cn gedt@xmu.edu.cn +86 592 2188502 +86 592 2188502.
Yang LiuKey Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University Xiamen 361005 China shiwei@xmu.edu.cn gedt@xmu.edu.cn +86 592 2188502 +86 592 2188502.
Fuhui ZhangXiamen Maternal and Child Health Hospital Xiamen 361003 China.
Yansheng ZhangXiamen Maternal and Child Health Hospital Xiamen 361003 China.
Yanan SunKey Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University Xiamen 361005 China shiwei@xmu.edu.cn gedt@xmu.edu.cn +86 592 2188502 +86 592 2188502.
Dongtao GeKey Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University Xiamen 361005 China shiwei@xmu.edu.cn gedt@xmu.edu.cn +86 592 2188502 +86 592 2188502.
Xiamen University · CNXiamen Maternal and Child Health Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The photothermal-chemical combination therapy is a promising approach for cancer treatment, however, chemotherapy often causes severe toxic and side effects on normal tissues. Herein, tumor-specific FeOOH@PNE-Art nanoparticles were fabricated

Identifiers

PMID35520919
PMCPMC9062392
OpenAlexW2928982607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.